jueves, 11 de junio de 2026
ClinicalTrials.gov: Essentials for Academic Medical Centers – Pre-recorded Training Video
SBIA Presents Virtual Training with Upcoming Panel Sessions - ClinicalTrials.gov: Essentials for Academic Medical Centers
This virtual training is designed to help staff at academic medical centers meet the federal requirements for registering clinical studies and reporting results on ClinicalTrials.gov. Specialists from the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will address frequently asked questions regarding regulatory obligations and the ClinicalTrials.gov Protocol Registration and Results System (PRS).
This training begins with a required, pre-recorded video that you can complete at your own pace prior to registering for any or all of the live panel sessions. Upon completion of the pre-recorded training, you can submit any questions you have about ClinicalTrials.gov registration and reporting via the dedicated email account ClinicalTrials.govAMCTraining@fda.hhs.gov and also through the registration process to attend a live virtual session with a panel of experts. The panel will use your questions to guide the discussion and provide relevant, practical answers. The live panel sessions are designed to build upon the information presented in the on-demand video.
Panel One: Tuesday, July 14: 1:00 PM ET
https://collaborationcqpub1.fda.gov/content/adobeconnect/213/7/en/events/event/private/164827404/284007766/event_landing.html?connect-session=breezbreezgpa8nssatuabktds&sco-id=284007767&_charset_=utf-8
Panel Two: Wednesday, July 22: 1:00 PM ET
https://collaborationcqpub1.fda.gov/content/adobeconnect/213/7/en/events/event/private/164827404/284017781/event_landing.html?connect-session=breezbreezgpa8nssatuabktds&sco-id=284022685&_charset_=utf-8
Panel Three: Thursday, July 30: 1:00 PM ET
https://collaborationcqpub1.fda.gov/content/adobeconnect/213/7/en/events/event/private/164827404/283989664/event_landing.html?connect-session=breezbreezgpa8nssatuabktds&sco-id=283997840&_charset_=utf-8
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario